Agilent Technologies, Inc. (NYSE:A) Shares Acquired by Vinva Investment Management Ltd

Vinva Investment Management Ltd increased its position in shares of Agilent Technologies, Inc. (NYSE:A) by 6.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 14,331 shares of the medical research company’s stock after purchasing an additional 878 shares during the quarter. Vinva Investment Management Ltd’s holdings in Agilent Technologies were worth $1,926,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Vestal Point Capital LP acquired a new position in Agilent Technologies in the third quarter valued at approximately $14,848,000. Sienna Gestion lifted its holdings in Agilent Technologies by 29.8% in the fourth quarter. Sienna Gestion now owns 78,445 shares of the medical research company’s stock valued at $10,537,000 after acquiring an additional 17,991 shares during the period. S.E.E.D. Planning Group LLC lifted its holdings in Agilent Technologies by 12.7% in the fourth quarter. S.E.E.D. Planning Group LLC now owns 42,587 shares of the medical research company’s stock valued at $5,721,000 after acquiring an additional 4,805 shares during the period. Sequoia Financial Advisors LLC lifted its holdings in Agilent Technologies by 8.5% in the fourth quarter. Sequoia Financial Advisors LLC now owns 33,898 shares of the medical research company’s stock valued at $4,554,000 after acquiring an additional 2,664 shares during the period. Finally, Miracle Mile Advisors LLC acquired a new position in Agilent Technologies in the fourth quarter valued at approximately $362,000. Institutional investors and hedge funds own 87.42% of the company’s stock.

Insiders Place Their Bets

In other Agilent Technologies news, VP Rodney Gonsalves sold 1,908 shares of the business’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the transaction, the vice president now owns 21,786 shares of the company’s stock, valued at approximately $2,657,456.28. The trade was a 8.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Padraig Mcdonnell sold 1,911 shares of the business’s stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the transaction, the chief executive officer now directly owns 39,652 shares in the company, valued at $5,947,800. This trade represents a 4.60 % decrease in their position. The disclosure for this sale can be found here. 0.26% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A has been the subject of a number of analyst reports. Bank of America decreased their price target on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a report on Friday, December 13th. Citigroup boosted their price objective on Agilent Technologies to $165.00 and gave the company a “buy” rating in a research report on Thursday, December 19th. Wells Fargo & Company cut their price objective on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research report on Monday, December 9th. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, December 24th. Finally, JPMorgan Chase & Co. cut their price objective on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research report on Tuesday, November 26th. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $146.15.

Agilent Technologies Stock Down 1.6 %

Shares of A opened at $120.23 on Friday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20. Agilent Technologies, Inc. has a one year low of $117.17 and a one year high of $155.35. The stock has a market capitalization of $34.28 billion, a price-to-earnings ratio of 27.64, a PEG ratio of 3.45 and a beta of 1.11. The stock has a 50 day moving average price of $137.07 and a 200 day moving average price of $137.45.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping the consensus estimate of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The firm had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Equities research analysts forecast that Agilent Technologies, Inc. will post 5.57 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be paid a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a yield of 0.83%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.76%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.